palmidrol has been researched along with Renal Insufficiency in 2 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is an important risk factor for kidney failure and renal events in the general population." | 1.39 | N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress. ( Calignano, A; d'Emmanuele di Villa Bianca, R; Mattace Raso, G; Meli, R; Mitidieri, E; Orefice, NS; Paciello, O; Pagano, TB; Pirozzi, C; Russo, R; Santoro, A; Simeoli, R, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattace Raso, G | 1 |
| Simeoli, R | 1 |
| Russo, R | 1 |
| Santoro, A | 1 |
| Pirozzi, C | 1 |
| d'Emmanuele di Villa Bianca, R | 1 |
| Mitidieri, E | 1 |
| Paciello, O | 1 |
| Pagano, TB | 1 |
| Orefice, NS | 1 |
| Meli, R | 1 |
| Calignano, A | 1 |
| Cordaro, M | 1 |
| Impellizzeri, D | 1 |
| Bruschetta, G | 1 |
| Siracusa, R | 1 |
| Crupi, R | 1 |
| Di Paola, R | 1 |
| Esposito, E | 1 |
| Cuzzocrea, S | 1 |
2 other studies available for palmidrol and Renal Insufficiency
| Article | Year |
|---|---|
N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Topics: Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cytochrome P-4 | 2013 |
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy.
Topics: Acute-Phase Proteins; Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Ur | 2016 |